In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-Protein

The recent development and mass administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines allowed for disease control, reducing hospitalizations and mortality. Most of these vaccines target the SARS-CoV-2 Spike (S) protein antigens, culminating with the production of ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira de Jesus, Bruna Andersen, Gomes, Anderson Albino, Clark, Alex E., Rodrigues, Tayse Andrade, Ledgerwood-Lee, Melissa, Van Zant, Westley, Brickner, Howard, Wang, Meiqiao, Blum, David L., Cassera, Maria B., Carlin, Aaron F., Aronoff-Spencer, Eliah S., da Silva, Gustavo Felippe, Magalhães, Maria de Lourdes Borba, Ray, Partha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780992/
https://www.ncbi.nlm.nih.gov/pubmed/36560827
http://dx.doi.org/10.3390/v14122823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780992/
https://www.ncbi.nlm.nih.gov/pubmed/36560827
http://dx.doi.org/10.3390/v14122823

Ejemplares similares